Tokyo, April 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061301) titled 'Effects of hip flexion training on muscle mass and sprint performance' on April 18.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - Active

Primary Sponsor: Institute - Ritsumeikan University

Condition: Condition - Healthy young individuals Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to examine the effects of hip flexion training on muscle volume and sprint performance and to compare these effects with those of knee extension training. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Participants will perform hip flexion training twice weekly for 12 weeks. Each session will be performed with a prescribed number of repetitions and sets. Interventions/Control_2 - Participants will perform knee extension training twice weekly for 12 weeks. Each session will be performed with a prescribed number of repetitions and sets.

Eligibility: Age-lower limit - 18 years-old = Gender - Male and Female Key inclusion criteria - Healthy young adults Key exclusion criteria - 1. Individuals who have performed resistance training involving hip flexion and knee extension (e.g., knee extension exercises, squats, deadlifts) at least twice per week for 12 weeks or more within the past year, or who are currently engaged in such training. 2. Individuals with conditions that may interfere with study participation, including hepatic, renal, or cardiovascular diseases; respiratory disorders; endocrine or metabolic disorders; neurological disorders; disturbances of consciousness; vestibular dysfunction; sleep disorders; cardiovascular and circulatory diseases; diabetes mellitus (as defined by the criteria of the Japan Diabetes Society); or other conditions such as peripheral vascular reflex disorders, acute inflammation, skin diseases, or malignant tumors. 3. Individuals who have reported minor injuries within the past 4 weeks or severe musculoskeletal injuries within the past 6 months. 4. Individuals who are unable or unwilling to provide informed consent. 5. Individuals presenting with severe physical or mental conditions at the time of participation. 6. Individuals with a history of claustrophobia or panic disorder. 7. Individuals who are unable to remain at rest. 8. Individuals who are pregnant. 9. Individuals with a history of epileptic seizures. 10. Individuals with implanted medical devices such as cardiac pacemakers, defibrillators, or artificial heart valves. 11. Individuals with metal in their body (e.g., dental orthodontic bridges, crowns depending on material, clips, etc.). 12. Individuals with tattoos (as tattoo ink may react to magnetic fields). Target Size - 40

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2024 Year 05 Month 01 Day Date of IRB - 2024 Year 09 Month 18 Day Anticipated trial start date - 2024 Year 09 Month 30 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070142

Disclaimer: Curated by HT Syndication.